Personnel Announcement
Novo Nordisk Pharma announced personnel changes for the Head of Medical Policy & Government Affairs, effective March 1, 2026.
📋 Article Processing Timeline
- 📰 Published: March 30, 2026 at 19:00
- 🔍 Collected: March 30, 2026 at 22:56 (3h 56m after Published)
- 🤖 AI Analyzed: April 16, 2026 at 08:46 (393h 50m after Collected)
Novo Nordisk Pharma Ltd. (President: Keisuke Kotani, Headquarters: Chiyoda-ku, Tokyo, hereinafter referred to as Novo Nordisk Pharma) announces the following personnel changes.
① Executive Personnel Changes (Effective March 1, 2026)
Name | New Position | Previous Position |
Ryo Kato (かとう りょう) | Head of Medical Policy & Government Affairs | Department Manager, Public Affairs Department, Medical Policy & Government Affairs |
Name | New Position | Previous Position |
Junko McMaster (McMaster Junko) | Director, Corporate Affairs Department | ― |
About Novo Nordisk
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases and improve the lives of people affected by them. To achieve this, we are discovering scientific innovations, expanding access to our medicines, and working to prevent disease and ultimately cure it. Novo Nordisk employs approximately 68,800 people in 80 countries, and its products are sold in about 170 countries. The Japanese subsidiary, Novo Nordisk Pharma Ltd., was established in 1980.
FAQ
When will the personnel changes take effect?
The personnel changes will take effect on March 1, 2026.
Who has been appointed as the new Head of Medical Policy & Government Affairs?
Ryo Kato has been appointed as the new Head of Medical Policy & Government Affairs.
What was Ryo Kato's previous position?
Ryo Kato's previous position was Department Manager of the Public Affairs Department within the Medical Policy & Government Affairs division.
What is Novo Nordisk Pharma's headquarters?
Novo Nordisk Pharma's headquarters are located in Chiyoda-ku, Tokyo.
What is the main business of Novo Nordisk?
Novo Nordisk is a global healthcare company focused on driving change to defeat serious chronic diseases and improve the lives of people affected by them, with a particular focus on diabetes.